Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
It's important to know when cash back credit cards incur taxes. Learn the key moments to prepare for potential tax impacts.
22,745 articlesA record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
A high-profile insider sale at Mineralys raises questions about what it might mean for the biotech's near-term trajec...
2026 is shaping up as the year Nvidia investors reconsider. While the stock once led the market, it now trails the S&...
As Rivian pivots toward the R2 and scalable production, investors wonder if the company can disrupt market reward in ...
Delve into the investing philosophy of Bill Miller IV, the CIO and PM behind Miller Value Fund. Learn how high-convic...
Dynatrace stock plummeted today after earnings beat but soft guidance signaled a cautious path ahead. This article br...
Investors buzzed as metals company stock rocketed higher on regulatory progress and strong demand signals for battery...
SpaceX signals a potential $75 billion IPO, elevating CFO Bret Johnsen to the center of a new phase focused on govern...
A veteran fund manager challenges Wall Street's reliance on earnings when valuing AI plays, arguing that the E in P/E...
As Apple eyes a leadership transition, analysts debate whether Apple stock will outpace the S&P 500 in the new CEO’s ...
In March, oil price declines helped airline stocks rally even as the broader market parsed mixed signals. This articl...
Amazon shares navigate a shifting tech landscape in 2026 as analysts map a path from near-term growth to a longer-ter...